Roman Mezencev

3.4k citations

86 papers · 2.4k indexed · 1 hit paper · h-index 29

Co-authors: John F. McDonald Todd Sulchek Lijuan Wang Byung Kyu Kim Wenwei Xu Peter Kutschy Lilya V. Matyunina Martina Bago Pilátová
Topics: Genomics, phytochemicals, and oxidative stress (11 papers)Computational Drug Discovery Methods (7 papers)Natural product bioactivities and synthesis (7 papers)
Cited by: Cell Biology Toxicology Cancer Research
Journals: Journal of Clinical Oncology PLoS ONE Scientific Reports
Partner nations: United States Slovakia Czechia

In The Last Decade

Roman Mezencev

81 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells

2012 603 citations Wenwei Xu, Roman Mezencev et al. PLoS ONE profile →

Peers

Countries citing papers authored by Roman Mezencev

Since Specialization

Citations

This map shows the geographic impact of Roman Mezencev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Mezencev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Mezencev more than expected).

Fields of papers citing papers by Roman Mezencev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Mezencev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Mezencev. The network helps show where Roman Mezencev may publish in the future.

Co-authorship network of co-authors of Roman Mezencev

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Mezencev. A scholar is included among the top collaborators of Roman Mezencev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Mezencev. Roman Mezencev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A ‘Chiron’ approach to novel phytosphingosine mimetics based on a cascade [3,3]-sigmatropic rearrangement 2024 ·Carbohydrate Research ·(unknown),(unknown),Miroslava Martinková,Martin Fábian,Martina Bago Pilátová,Josef Cvačka,(unknown),Roman Mezencev	1
2	Interactions between chromium species and DNA in vitro and their potential role in the toxicity of hexavalent chromium 2023 ·Metallomics ·Roman Mezencev,Catherine Gibbons	9
3	Ceramides and their roles in programmed cell death 2023 ·Advances in Medical Sciences ·Martina Bago Pilátová,Zuzana Solárová,Roman Mezencev,Peter Solár	26
4	Correlating mechanical and gene expression data on the single cell level to investigate metastatic phenotypes 2023 ·iScience ·Katherine Young,(unknown),(unknown),Roman Mezencev,(unknown),(unknown),(unknown),(unknown),J. F. McDonald,Peng Qiu,Todd Sulchek	7
5	Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines 2021 ·Toxicology and Applied Pharmacology ·Roman Mezencev,Scott S. Auerbach	8
6	Correlating Mechanical and Gene Expression Data on the Single Cell Level to Investigate Metastasis 2020 ·Biophysical Journal ·Katherine Young,Congmin Xu,(unknown),Roman Mezencev,Peng Qiu,Todd Sulchek	1
7	Epidemiology of gliomas in women diagnosed with breast cancer supports the protective role of estrogenic exposure 2018 ·Bratislavské lekárske listy/Bratislava medical journal ·Roman Mezencev	5
8	P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens 2017 ·Annals of Diagnostic Pathology ·Marián Švajdler,Roman Mezencev,Ondřej Ondič,(unknown),Petr Mukenšnábl,Michal Michal	15
9	Open source machine-learning algorithms for the prediction of optimal cancer drug therapies 2017 ·PLoS ONE ·Cai Huang,Roman Mezencev,John F. McDonald,Fredrik Vannberg	84
10	Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity 2016 ·Scientific Reports ·Minati Satpathy,Roman Mezencev,Lijuan Wang,John F. McDonald	26
11	Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population 2015 ·Neoplasma ·Marián Švajdler,(unknown),Roman Mezencev,Ján Laco,(unknown),P. Dubinský,Ľ Straka,Ondřej Ondič,(unknown),Alena Skálová	20
12	Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex 2015 ·Current Cancer Drug Targets ·Roman Mezencev	71
13	Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells 2013 ·Bulletin of the American Physical Society ·Wenwei Xu,Roman Mezencev,Byung Kyu Kim,Lijuan Wang,John McDonald,Todd Sulchek	0
14	Mechanical stiffness as an improved single-cell indicator of osteoblastic human mesenchymal stem cell differentiation 2013 ·Journal of Biomechanics ·(unknown),(unknown),Roman Mezencev,Sarah Griffiths,René Olivares‐Navarrete,John F. McDonald,Zvi Schwartz,Barbara D. Boyan,Todd C. McDevitt,Todd Sulchek	60
15	The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin 2013 ·Bioorganic & Medicinal Chemistry ·Mariana Budovská,Martina Bago Pilátová,Lenka Varinská,Ján Mojžíš,Roman Mezencev	37
16	Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cellsbreakdown → 2012 ·PLoS ONE ·Wenwei Xu,Roman Mezencev,Byung Kyu Kim,Lijuan Wang,John F. McDonald,Todd Sulchek	603
17	The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species 2012 ·Journal of Natural Medicines ·(unknown),(unknown),Mahandranauth A. Chetram,BaoHan T. Vo,Roman Mezencev,Cimona V. Hinton,Valerie Odero-Marah	20
18	The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated 2012 ·BMC Medical Genomics ·(unknown),Lilya V. Matyunina,(unknown),Lijuan Wang,Roman Mezencev,L. DeEtte Walker,John F. McDonald	29
19	Rapid Mass Spectrometric Metabolic Profiling of Blood Sera Detects Ovarian Cancer with High Accuracy 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Manshui Zhou,(unknown),L. DeEtte Walker,Roman Mezencev,Benedict B. Benigno,Alexander Gray,Facundo M. Fernández,John F. McDonald	60
20	The design, synthesis and anticancer activity of new nitrogen mustard derivatives of natural indole phytoalexin 1-methoxyspirobrassinol 2009 ·Neoplasma ·Roman Mezencev,Peter Kutschy,Aneta Salayová,Taylor B. Updegrove,Jane McDonald	14

About Roman Mezencev

Roman Mezencev is a scholar working on Cancer Research, Otorhinolaryngology and Oncology, having authored 86 papers that have together received 2.4k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (11 papers), Computational Drug Discovery Methods (7 papers) and Natural product bioactivities and synthesis (7 papers). The work is most often cited by research in Cell Biology (523 citations), Toxicology (101 citations) and Cancer Research (415 citations). Roman Mezencev has collaborated with scholars based in United States, Slovakia and Czechia. Frequent co-authors include John F. McDonald, Todd Sulchek, Lijuan Wang, Byung Kyu Kim, Wenwei Xu, Peter Kutschy, Lilya V. Matyunina, Martina Bago Pilátová, Marián Švajdler and Ján Mojžíš. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact